JUBEREQ Trademark

Trademark Overview

On Monday, January 15, 2024, a trademark application was filed for JUBEREQ with the United States Patent and Trademark Office. The USPTO has given the JUBEREQ trademark a serial number of 79391361. The federal status of this trademark filing is REGISTERED as of Tuesday, April 29, 2025. This trademark is owned by Accord Healthcare Limited. The JUBEREQ trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.
jubereq

General Information

Serial Number79391361
Word MarkJUBEREQ
Filing DateMonday, January 15, 2024
Status700 - REGISTERED
Status DateTuesday, April 29, 2025
Registration Number7772704
Registration DateTuesday, April 29, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2025

Trademark Statements

Translation of Words in MarkThe wording JUBEREQ has no meaning in a foreign language.
Goods and Servicespharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccord Biopharma, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressUS
Party NameAccord Healthcare Limited
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressGB
Party NameAccord Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressGB
Party NameAccord Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressGB

Trademark Events

Event DateEvent Description
Thursday, March 14, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Sunday, March 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2024APPLICATION FILING RECEIPT MAILED
Friday, August 9, 2024ASSIGNED TO EXAMINER
Tuesday, August 13, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 21, 2024REFUSAL PROCESSED BY MPU
Wednesday, August 21, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 9, 2024REFUSAL PROCESSED BY IB
Friday, February 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 5, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 11, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 11, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 29, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 29, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, August 13, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 13, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 5, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, September 25, 2025CHANGE OF OWNER RECEIVED FROM IB
Wednesday, November 19, 2025FINAL DISPOSITION PROCESSED
Wednesday, November 19, 2025FINAL DISPOSITION NOTICE SENT TO IB
Thursday, December 18, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

jubereq pharmaceutical cancer treatment preparations substances products prevention therewith disorders oncological